Generic Name: Emtricitabine and Tenofovir disoproxil fumarate
TENOF EM Tablets by Hetero, also known as Tenofovir Disoproxil Fumarate and Emtricitabine Tablets, are a medication commonly used in the treatment of HIV (human immunodeficiency virus) infection.
These tablets are part of a class of drugs known as antiretrovirals, which help manage and control the progression of HIV.
TENOF EM Tablets contain two active ingredients:

• Tenofovir Disoproxil Fumarate: This is a nucleotide analog reverse transcriptase inhibitor that inhibits the replication of the HIV virus.


• Emtricitabine: An NRTI (nucleoside reverse transcriptase inhibitor), which also impedes HIV replication.

In some cases, TENOF EM Tablets may also be prescribed as PrEP for individuals at high risk of HIV infection to reduce their chances of acquiring the virus.

• Customer-Centric Solutions: Parshva Agency focuses on delivering tailored private labeling services on a Peer-to-Peer (P2P) basis to meet the unique needs of each client.
• Regulatory Support: The agency is backed by experienced regulatory experts who ensure full compliance with all industry standards, providing peace of mind to clients.
• State-of-the-Art Manufacturing: Partnered with advanced manufacturing facilities that meet WHO-GMP certifications, Parshva Agency emphasizes the importance of modern production techniques.
• Quality and Efficacy: With WHO-GMP certification, the agency guarantees that its products maintain the highest standards of quality and efficacy.
• Reliability: Parshva Agency is committed to providing safe, reliable, and compliant products that meet stringent regulatory guidelines, fostering trust among clients and stakeholders.